Table II.
Association between high bone morphogenetic protein receptor 2 expression with clinicopathological characteristics of osteosarcoma.
| Factors | OR | CI | P-value | Value, n |
|---|---|---|---|---|
| Sex, female vs. male | 0.908 | 0.638–1.291 | 0.629 | 71 |
| Age, <16 vs. ≥16 years | 1.047 | 0.743–1.473 | 0.825 | 83 |
| Tumor site, femur vs. tibia/fibula | 0.856 | 0.577–1.268 | 0.466 | 68 |
| Metastasis within 5 years, yes vs. no | 2.794 | 1.282–6.089 | 0.001 | 53 |
| Histological subtype | ||||
| Osteolastic vs. chondroblastic | 0.985 | 0.637–1.523 | 1.000 | 68 |
| Osteolastic vs. fibroblastic | 1.436 | 0.594–3.469 | 0.427 | 59 |
| Huvos grade, 1 and 2 vs. 3 and 4 | 0.908 | 0.638–1.291 | 0.629 | 71 |
OR, odds ratio; CI, confidence interval.